Issue of shares & total voting rights

RNS Number : 0171Q
Inspiration Healthcare Group PLC
16 June 2020
 

16 June 2020

 

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

 

Issue of shares & total voting rights

The Board of Inspiration Healthcare confirms that, pursuant to the acquisition of Vio Holdings Limited ("Vio Holdings") announced on 5 September 2019 (the "Acquisition"), it has issued 671,296   new ordinary shares of 10 pence each in the Company ("Ordinary Shares) to the vendors of Vio Holdings in full and final settlement of the deferred consideration arrangements relating to the Acquisition.

 

Application has been made for the Admission to trading of the 671,296 new Ordinary Shares. It is expected that Admission of the new Ordinary Shares will occur at 8:00 a.m. on 18 June 2020. Following this issue, the total number of Ordinary Shares in issue will be 39,052,146. The Company does not hold any shares in treasury.

 

The above figure of 39,052,146 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

Jon Ballard, Financial Controller

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR 

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

 

 

About Inspiration Healthcare   http://www.inspiration-healthcare.com

 

Inspiration Healthcare is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

 

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe. In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance. Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEELFFBQLZBBL
UK 100

Latest directors dealings